Latest read on rare disease gene therapy from Insmed CEO Will Lewis
CNBC Televisionยท2025-11-03 23:13
joining us on set for more Inset CEO Will Lewis. Will great to have you with us. Um Guy was remarking that the first time you were on the show the stock was what $30.So this has been quite a journey that you've been on. During this past quarter we had the launch of Burn Supri which had been better than what analysts had been expected. Q4 though >> should be the test.So can you sort of walk us through the push and pulls um going into Q4 there was some indication on the calls. understand it that there could b ...